Precision Biosciences (DTIL) Revenue (QoQ) (2018 - 2026)
Precision Biosciences (DTIL) Revenue (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,102.16 Bn | 67,101.87 Bn | - |
| 2 | Nanobiotix | 1,913.50 Bn | 1,913.44 Bn | - |
| 3 | Akari Therapeutics | 959.56 Bn | 959.56 Bn | - |
| 4 | BeOne Medicines | 472.39 Bn | 467.60 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 122.08 Bn | 114.83 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.98 Bn | 61.22 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.34 Bn | 62.34 Bn | - |
| 8 | Argenx Se | 55.97 Bn | 50.78 Bn | 1.41 Bn |
| 9 | Alnylam Pharmaceuticals | 37.47 Bn | 34.46 Bn | 959.66 Mn |
| 10 | Precision Biosciences | 182.42 Mn | 154.13 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -68.31% |
| Dec 31, 2025 | 263,007.69% |
| Sep 30, 2025 | -27.78% |
| Jun 30, 2025 | -37.93% |
| Mar 31, 2025 | -95.45% |
| Dec 31, 2024 | 10.76% |
| Sep 30, 2024 | -98.85% |
| Jun 30, 2024 | 183.77% |
| Mar 31, 2024 | 149.84% |
| Dec 31, 2023 | -46.36% |
| Sep 30, 2023 | -33.70% |
| Jun 30, 2023 | 125.39% |
| Mar 31, 2023 | -17.15% |
| Dec 31, 2022 | 43.94% |
| Sep 30, 2022 | 92.75% |
| Jun 30, 2022 | 15.16% |
| Mar 31, 2022 | -47.67% |
| Dec 31, 2021 | -73.63% |
| Sep 30, 2021 | -65.07% |
| Jun 30, 2021 | 320.85% |